BIOTEST AG (BIO.DE) Stock Cash Flow
FRA:BIO - Deutsche Boerse Ag - DE0005227201 - Common Stock - Currency: EUR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 127.00M | -31.70M | -62.70M | -30.00M | -1.30M | |||
| Depreciation Amortization | 35.90M | 35.80M | 31.10M | 29.60M | 31.70M | |||
| Change In Working Capital | -156.70M | -60.30M | 48.00M | -41.30M | -65.10M | |||
| Interest Paid | 24.20M | 13.10M | 12.80M | 6.60M | 4.70M | |||
| Taxes Paid | 11.70M | 2.00M | 900.00K | 2.00M | 1.10M | |||
| Other non cash items | -8.90M | 15.70M | 17.50M | 25.00M | 1.10M | |||
| OPERATING CASH FLOW | -2.70M | -40.50M | 33.90M | -16.70M | -33.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -33.40M | -29.30M | -18.20M | -27.00M | -34.10M | |||
| Other Investing Activity | 34.70M | -7.70M | -5.20M | 12.40M | 26.10M | |||
| INVESTING CASH FLOW | 1.30M | -37.00M | -23.40M | -14.60M | -8.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -8.90M | 94.20M | 19.80M | 42.70M | 38.60M | |||
| Dividend Paid | 0.00 | -800.00K | -800.00K | -800.00K | -800.00K | |||
| Other Financing Activity | 2.10M | -3.80M | 3.60M | 100.00K | 2.70M | |||
| FINANCING CASH FLOW | -6.80M | 89.60M | 22.60M | 42.00M | 40.50M | |||
| Exchange Rate Effect | 100.00K | 0.00 | 0.00 | -200.00K | N/A | |||
| CHANGE IN CASH | -8.10M | 12.10M | 33.10M | 10.50M | -1.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.70M | -40.50M | 33.90M | -16.70M | -33.60M | |||
| Capital Expenditure | -33.40M | -29.30M | -18.20M | -27.00M | -34.10M | |||
| FREE CASH FLOW | -36.10M | -69.80M | 15.70M | -43.70M | -67.70M | |||
All data in EUR